47 Followers on Owler
OverviewCompetitorsFundingNews & Insights

G1 Therapeutics Funding History

Since G1 Therapeutics was founded in 2008, it has participated in 8 rounds of funding. In total G1 Therapeutics has raised $349.4M. G1 Therapeutics' last funding round was on Nov 2022 for a total of $46.8M.

G1 Therapeutics Funding Rounds

Unlock 5 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Post-IPO Equity
Nov 2022
$46.8M
__
Post-IPO Debt
May 2020
$100M
1
Hercules Capital
IPO
May 2017
$105M
__
Series C
Apr 2016
$50M
4
Hatteras Venture Partners,  MedImmune Ventures,  RA Capital Management,  Eshelman Ventures
Series B
Feb 2015
$33M
6
Eshelman Ventures,  RA Capital Management, LLC,  Lumira Capital,  Hatteras Venture Partners,  MedImmune Ventures,  Mountain Group Capital, LLC

Total Funding: $349.4M

G1 Therapeutics Investors

Unlock 6 more investors →

INVESTOR

ROUND

FUNDING DATE

Hercules Capital
Post-IPO Debt
May 2020
Hatteras Venture Partners
Series C, Series B, Series A, Debt
Apr 2016, Feb 2015, Oct 2013, Apr 2013
MedImmune Ventures
Series C, Series B, Series A, Debt
Apr 2016, Feb 2015, Oct 2013, Apr 2013
RA Capital Management
Series C
Apr 2016
Eshelman Ventures
Series C, Series B
Apr 2016, Feb 2015

Total Investors: 9

G1 Therapeutics has 9 investors, including Hercules Capital, Hatteras Venture Partners and MedImmune Ventures. The latest investment occurred in Nov 2022.